| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/20/2011 | EP1648485B1 Formulation for a protein pharmaceutical without added human serum albumin (hsa) |
| 04/20/2011 | EP1624892B1 Therapeutic use of anti-cs1 antibodies |
| 04/20/2011 | EP1532149B9 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 04/20/2011 | EP1511471B9 Colloidal suspension of submicronic particles for delivering active principles and method for preparing same |
| 04/20/2011 | EP1480681B1 Coupling low-molecular substances to a modified polysaccharide |
| 04/20/2011 | EP1399161B1 Sustained-release analgesic compounds |
| 04/20/2011 | CN201798930U Medicament slowly controlled releaser |
| 04/20/2011 | CN1943787B A damp proof composition for pharmaceutical and its preparation methods |
| 04/20/2011 | CN1930190B Hyaluronic acid derivative and drug containing the same |
| 04/20/2011 | CN1909929B Anti-inflammatory analgesic for external use |
| 04/20/2011 | CN1876040B Detection method of pharmaceutical composition for treating hepatitis |
| 04/20/2011 | CN1875953B Percutaneous absorption-type pharmaceutical preparation |
| 04/20/2011 | CN1655767B Coated particles with prolonged release and tablets containing same |
| 04/20/2011 | CN102027043A Biodegradable cross-linked branched poly (alkylene imines) |
| 04/20/2011 | CN102027019A High-density lipoprotein-like peptide-phospholipid scaffold (''HPPS'') nanoparticles |
| 04/20/2011 | CN102026671A Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
| 04/20/2011 | CN102026669A Conjugates for the treatment of mesothelioma |
| 04/20/2011 | CN102026668A Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging |
| 04/20/2011 | CN102026667A Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use |
| 04/20/2011 | CN102026666A Formulation of insulinotropic peptide conjugates |
| 04/20/2011 | CN102026665A Pharmaceutical compositions having carboxyvinyl polymer and povidone polymer |
| 04/20/2011 | CN102026664A Composition for stabilizing Beta-blocker, and transdermally absorbable preparation comprising the composition |
| 04/20/2011 | CN102026663A Controlled release of active agents from oleosomes |
| 04/20/2011 | CN102026662A Stabilized oleosome preparations and methods of making them |
| 04/20/2011 | CN102026657A Vaccines for malaria |
| 04/20/2011 | CN102026630A Film-shaped preparation comprising oily substances for oral administration |
| 04/20/2011 | CN102026629A Transdermally absorbable preparation |
| 04/20/2011 | CN102026628A Oral controlled release tablet with reduced burst effect |
| 04/20/2011 | CN102026626A Granulate comprising escitalopram oxalate |
| 04/20/2011 | CN102026625A Dithiocarbamate metal chelates and methods of making and using thereof |
| 04/20/2011 | CN102026623A Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 04/20/2011 | CN102026622A Improved topical ophthalmic compositions |
| 04/20/2011 | CN102026621A Stable pharmaceutical formulations |
| 04/20/2011 | CN102026619A Liquid buffered GDF-5 formulations |
| 04/20/2011 | CN102021074A Thermally sensitive plant-aromatic controlled-release granules and preparation method thereof |
| 04/20/2011 | CN102020855A Electrostatic spraying forming method of amino-acid ester substituted polyphosphazene microspheres |
| 04/20/2011 | CN102020816A Polyvinyl formal sponge material with uniform abscesses and rapid imbibition and preparation method thereof |
| 04/20/2011 | CN102020765A Preparation methods of poly (aspartic acid-co-lactic acid) graft polymer and nanoparticles of poly (aspartic acid-co-lactic acid) graft polymer |
| 04/20/2011 | CN102018962A Polymer intensifier in controlled release preparation |
| 04/20/2011 | CN102018961A Protective agent for nano-emulsion |
| 04/20/2011 | CN102018960A Method for keeping quality stability of clindamycin phosphate injection |
| 04/20/2011 | CN102018953A Pharmaceutical composition containing nocathiacin antibiotics |
| 04/20/2011 | CN102018867A Medical composition containing chondroitin sulfuric acid and/or medical salt thereof and garlic oil |
| 04/20/2011 | CN102018780A Skin bacteriostatic agent and preparation method thereof |
| 04/20/2011 | CN102018763A Linseed oil fat emulsion intravenous injection fluid and production method thereof |
| 04/20/2011 | CN102018736A Natural indigo decoction piece and preparation method thereof |
| 04/20/2011 | CN102018735A External ointment for treating mump |
| 04/20/2011 | CN102018732A Medicinal composition consisting of chondroitin sulfate and/or medicinal salt thereof and ginkgo leaf extract |
| 04/20/2011 | CN102018721A Chewable tablet of calcium carbonate dimeticone and preparation process |
| 04/20/2011 | CN102018714A Formulations |
| 04/20/2011 | CN102018700A Pharmaceutical preparation containing silymarin and preparation thereof |
| 04/20/2011 | CN102018696A Skin external preparation containing lidocaine or pharmaceutical salt thereof |
| 04/20/2011 | CN102018695A Atenolol soft capsule and preparation method thereof |
| 04/20/2011 | CN102018686A Mitomycin-containing film agent and preparation method thereof |
| 04/20/2011 | CN102018685A Terazosin pellicle and preparation method thereof |
| 04/20/2011 | CN102018684A Candesartan cilexetil self-microemulsion soft capsule and preparation method thereof |
| 04/20/2011 | CN102018683A Effervescent tablet containing piracetam |
| 04/20/2011 | CN102018682A Osmotic pump controlled-release tablet and preparation method thereof |
| 04/20/2011 | CN102018680A Emedastine difumarate sustained release tablets and preparation method thereof |
| 04/20/2011 | CN102018679A Azithromycin dispersing tablet with improved mouthfeel and preparation method of same |
| 04/20/2011 | CN102018677A Roxatidine acetate hydrochloride used for injection and preparation method thereof |
| 04/20/2011 | CN102018676A Method for preparing water-soluble medicine naonparticles and suspension aerosol thereof |
| 04/20/2011 | CN102018674A Diclofenac sodium hydrogel microballoon with pH sensitivity, preparation method and application thereof |
| 04/20/2011 | CN102018673A Adenosine triphosphate precursor liposome as well as preparation method and application thereof |
| 04/20/2011 | CN102018672A Freeze-dried liposome composition of water-soluble medicament and preparation method thereof |
| 04/20/2011 | CN102018671A Estradiol transdermal spray and preparation method thereof |
| 04/20/2011 | CN102018670A Anticancer preparation and preparation method thereof |
| 04/20/2011 | CN102018668A Preparation method of aceglutamide |
| 04/20/2011 | CN102018666A Preparation method and new clinic application of penciclovir injection solution |
| 04/20/2011 | CN102018665A Strictosamide injection and preparation method thereof |
| 04/20/2011 | CN102018664A Preparation of compound/sodium chloride |
| 04/20/2011 | CN102018663A Preparation of compound/glucose |
| 04/20/2011 | CN102018660A Naftopidil suppository and preparation method thereof |
| 04/20/2011 | CN102018658A Controlled release preparation and preparation method thereof |
| 04/20/2011 | CN102018657A Solid dispersoid containing progestational hormone, preparation method thereof and composite comprising same |
| 04/20/2011 | CN102018656A Eye gel containing latanoprost used as effective component and preparation method thereof |
| 04/20/2011 | CN101732326B Method for preparing vitamin D3 nutrient complex |
| 04/20/2011 | CN101693020B Enteric soluble medicine empty capsule prepared by replacing part of gelatin with defatted soybean meal extractive and preparation process |
| 04/20/2011 | CN101647776B Doxofylline venous injection with small volume as well as preparation method and quality control method thereof |
| 04/20/2011 | CN101584664B Cefodizime sodium proliposome preparation and preparation method thereof |
| 04/20/2011 | CN101548977B Composition of cefmetazole acid |
| 04/20/2011 | CN101548947B Docetaxel nanometer lipid injection, preparation method and purpose thereof |
| 04/20/2011 | CN101537184B Composition containing water-insoluble high-activity drug and preparation method thereof |
| 04/20/2011 | CN101537030B Paste for treating physical trauma |
| 04/20/2011 | CN101524355B Compound preparation of antituberculosis medicaments, and preparation method thereof |
| 04/20/2011 | CN101502484B Glucocorticosteroid and chemotherapy medicament carried by anticancer sustained-release agent |
| 04/20/2011 | CN101496858B Chinese medicinal composition for treating insomnia and preparation method thereof |
| 04/20/2011 | CN101491508B Preparation method of aspirin Intestine-soluble micro-pill capsules |
| 04/20/2011 | CN101474171B Oral solid preparation of escitalopram oxalate and preparation method thereof |
| 04/20/2011 | CN101412747B Novel cell-penetrating peptide and uses thereof |
| 04/20/2011 | CN101411685B Intravenous anesthetics 2,6-diisopropyl phenol microemulsion composition and method of making the same |
| 04/20/2011 | CN101390856B Solid preparation of clopidogrel and preparation method thereof |
| 04/20/2011 | CN101342164B Bezafibrate controlled release formulation and preparation method thereof |
| 04/20/2011 | CN101342153B Risperidone osmotic pump controlled release tablets and preparation method thereof |
| 04/20/2011 | CN101264064B Vinpocetine freeze-dried powder for injection and preparation thereof |
| 04/20/2011 | CN101260191B Temperature sensitive type chitosan/glutin hydrogel and its preparation method and use |
| 04/20/2011 | CN101240027B Conjugate constructed from normal nonyl and RGD peptide, and its synthesis and application in medicine |
| 04/20/2011 | CN101224306B Folic acid-polypeptide compound-mediated targeting anti-tumor prodrug and preparing method thereof |
| 04/20/2011 | CN101199856B Oxygen-carrying anti-shock medicament |
| 04/20/2011 | CN101195031B Gluconic acid modified chitosan nucleophilic NO donator and synthesizing method thereof |